We have previously reported a significant and sometimes striking enrichment in CD4+CD25+ T cells among tumour-infiltrating lymphocytes in patients with SCCHN (Albers et al, 2004), and thus we hypothesise that these cells may preferentially localise to tumour sites. The gene discussed is CD4; the disease is neoplasm.